NEUROLOGY 2004;62:S2-S8
© 2004 American Academy of Neurology
| Neurology supplements are not peer-reviewed. Information contained in Neurology supplements represent the opinions of the authors and are not endorsed by nor do they reflect the views of the American Academy of Neurology, Editor-in-Chief, or Associate Editors of Neurology.
|
Migraine throughout the life cycle
Treatment through the ages
Stephen Landy, MD
From the Wesley Headache Clinic, Memphis, TN.
Address correspondence and reprint requests to Dr. Stephen Landy, Wesley Headache Clinic, 8974 Bridge Forest Drive, Memphis, TN 38138.
Migraine seriously impairs the quality of life in those who suffer from it and exacts a high socioeconomic cost in lost productivity. About half of all persons with migraine go undiagnosed. To avoid misdiagnosis of migraine, clinicians must be prepared to recognize atypical presentations, including tension headache-like and "sinus" symptoms. Nonpharmacologic treatments, including relaxation training and thermal or EMG biofeedback training, may be appropriate for some patients. Pharmacotherapy for migraine may be acute or preventive. In prescribing treatment, the clinician should consider the characteristics of the patient’s headaches, the patient’s medication history and preferences, and co-morbidities. For acute treatment in patients with more severe migraine and those whose headaches respond poorly to nonsteroidal anti-inflammatory drugs or combination analgesics, migraine-specific agents, such as triptans, dihydroergotamine, and ergotamine, are recommended. Early intervention—identifying and treating the headache during the mild phase—is often a key to successful management. Preventive treatment of migraine may be appropriate to reduce the frequency, severity, and duration of migraine attacks, to improve the response to acute treatment, and to reduce disability. Clinicians who treat migraine must be aware of considerations specific to children, women, and the elderly.
This article has been cited by other articles:
|
|
|
|
 
Y. J. Lee, H.-C. Kang, J. S. Lee, S. H. Kim, D.-S. Kim, K.-W. Shim, Y.-H. Lee, T. S. Kim, and H. D. Kim
Resective Pediatric Epilepsy Surgery in Lennox-Gastaut Syndrome
Pediatrics,
January 1, 2010;
125(1):
e58 - e66.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. W. Mathern
Epilepsy surgery patients with cortical dysplasia: Present and future therapeutic challenges
Neurology,
January 20, 2009;
72(3):
206 - 207.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Krsek, B. Maton, P. Jayakar, P. Dean, B. Korman, G. Rey, C. Dunoyer, E. Pacheco-Jacome, G. Morrison, J. Ragheb, et al.
Incomplete resection of focal cortical dysplasia is the main predictor of poor postsurgical outcome
Neurology,
January 20, 2009;
72(3):
217 - 223.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Salamon, J. Kung, S. J. Shaw, J. Koo, S. Koh, J. Y. Wu, J. T. Lerner, R. Sankar, W. D. Shields, J. Engel Jr, et al.
FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy
Neurology,
November 11, 2008;
71(20):
1594 - 1601.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. E. Jung, H. C. Kang, and H. D. Kim
Long-Term Outcome of the Ketogenic Diet for Intractable Childhood Epilepsy With Focal Malformation of Cortical Development
Pediatrics,
August 1, 2008;
122(2):
e330 - e333.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. W. Kim, K. -K. Kim, K. Chu, C. -K. Chung, and S. K. Lee
Surgical treatment of delayed epilepsy in hemiconvulsion-hemiplegia-epilepsy syndrome
Neurology,
May 27, 2008;
70(22_Part_2):
2116 - 2122.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Suthisisang, N. Poolsup, W. Kittikulsuth, P. Pudchakan, and P. Wiwatpanich
Efficacy of Low-Dose Ibuprofen in Acute Migraine Treatment: Systematic Review and Meta-Analysis
Ann. Pharmacother.,
November 1, 2007;
41(11):
1782 - 1791.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Schindler, H. Leung, K. Lehnertz, and C. E Elger
How generalised are secondarily "generalised" tonic clonic seizures?
J. Neurol. Neurosurg. Psychiatry,
September 1, 2007;
78(9):
993 - 996.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T Kral, M von Lehe, M Podlogar, H Clusmann, P Sussmann, M Kurthen, A Becker, H Urbach, and J Schramm
Focal cortical dysplasia: long term seizure outcome after surgical treatment
J. Neurol. Neurosurg. Psychiatry,
August 1, 2007;
78(8):
853 - 856.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. S. Chandra, N. Salamon, S. T. Nguyen, J. W. Chang, M. N. Huynh, C. Cepeda, J. P. Leite, L. Neder, S. Koh, H. V. Vinters, et al.
Infantile spasm-associated microencephaly in tuberous sclerosis complex and cortical dysplasia
Neurology,
February 6, 2007;
68(6):
438 - 445.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Loup, F. Picard, V. M. Andre, P. Kehrli, Y. Yonekawa, H.-G. Wieser, and J.-M. Fritschy
Altered expression of {alpha}3-containing GABAA receptors in the neocortex of patients with focal epilepsy
Brain,
December 1, 2006;
129(12):
3277 - 3289.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. S. Tozer, E. A. Boatwright, P. S. David, D. P. Verma, J. E. Blair, A. P. Mayer, and J. A. Files
Prevention of Migraine in Women Throughout the Life Span
Mayo Clin. Proc.,
August 1, 2006;
81(8):
1086 - 1092.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Barkovich, R. I. Kuzniecky, G. D. Jackson, R. Guerrini, and W. B. Dobyns
A developmental and genetic classification for malformations of cortical development
Neurology,
December 27, 2005;
65(12):
1873 - 1887.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Yamanouchi
Topical Review: Activated Remodeling and N-Methyl-D-Aspartate (NMDA) Receptors in Cortical Dysplasia
J Child Neurol,
April 1, 2005;
20(4):
303 - 307.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Kakita, S. Kameyama, S. Hayashi, H. Masuda, and H. Takahashi
Pathologic Features of Dysplasia and Accompanying Alterations Observed in Surgical Specimens From Patients With Intractable Epilepsy
J Child Neurol,
April 1, 2005;
20(4):
341 - 350.
[Abstract]
[PDF]
|
|
|
|
|
|
|
H. Otsubo, K. Iida, M. Oishi, C. Okuda, A. Ochi, E. Pang, S. K. Weiss, J. T. Rutka, S. H. Chuang, and O. C. Snead III
Neurophysiologic Findings of Neuronal Migration Disorders: Intrinsic Epileptogenicity of Focal Cortical Dysplasia on Electroencephalography, Electrocorticography, and Magnetoencephalography
J Child Neurol,
April 1, 2005;
20(4):
357 - 363.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. Sakuta, H. Otsubo, M. A. Nolan, S. K. Weiss, C. Hawkins, J. T. Rutka, N. A. Chuang, S. H. Chuang, and O. C. Snead III
Recurrent Intractable Seizures in Children With Cortical Dysplasia Adjacent to Dysembryoplastic Neuroepithelial Tumor
J Child Neurol,
April 1, 2005;
20(4):
377 - 384.
[Abstract]
[PDF]
|
|
|
|
|
|
|
H. Yamanouchi
Topical Review: Activated Remodeling and N-Methyl-D-Aspartate (NMDA) Receptors in Cortical Dysplasia
J Child Neurol,
March 1, 2004;
19(3):
303 - 307.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Kakita, S. Kameyama, S. Hayashi, H. Masuda, and H. Takahashi
Pathologic Features of Dysplasia and Accompanying Alterations Observed in Surgical Specimens from Patients with Intractable Epilepsy
J Child Neurol,
March 1, 2004;
19(3):
341 - 350.
[Abstract]
[PDF]
|
|
|
|
|
|
|
H. Otsubo, K. Iida, M. Oishi, C. Okuda, A. Ochi, E. Pang, S. K. Weiss, J. T. Rutka, S. H. Chuang, and O. Carter Snead
Neurophysiologic Findings of Neuronal Migration Disorders: Intrinsic Epileptogenicity of Focal Cortical Dysplasia on Electroencephalography, Electrocorticography, and Magnetoencephalography
J Child Neurol,
March 1, 2004;
19(3):
357 - 363.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. Sakuta, H. Otsubo, M. A. Nolan, S. K. Weiss, C. Hawkins, J. T. Rutka, N. A. Chuang, S. H. Chuang, and O. Carter Snead
Recurrent Intractable Seizures in Children With Cortical Dysplasia Adjacent to Dysembryoplastic Neuroepithelial Tumor
J Child Neurol,
March 1, 2004;
19(3):
377 - 384.
[Abstract]
[PDF]
|
|
|
|
